Delivery Order SPE2DB20D2104-SPE2DB25F1253

Award Date 11/1/24
Potential Completion Date 11/25/24
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 mg/mL autoinjectors. The $11,172.12 firm fixed-price contract has an ultimate completion date of August 9, 2024. AmerisourceBergen holds several notable Indefinite Delivery Contracts (IDCs) with the DLA and the Department of Justice Federal Bureau of Investigation, valued up to $999,999,999 and $750,000 respectively, for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,889.56 firm fixed-price delivery order is for the supply of Benlysta 200 mg/mL autoinjector medication. The contract has an ultimate completion date of December 12, 2024 and was awarded on November 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjector. The single-award contract has a firm fixed price of $10,805.40 and an ultimate completion date of September 7, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a $2,556.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for Benlysta 200 mg/mL autoinjector medication, with a performance period through December 29, 2022. It is not designated as a set-aside contract. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BENLYSTA 200 MG/ML AUTOINJECTML. The fixed-price contract has a ceiling value of $3,082.67 and runs through February 27, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through November 2026, which serves as a primary vehicle for providing a comprehensive...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjectors. The contract, valued at $5,779.12, has an ultimate completion date of January 14, 2025. This award is associated with AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This federal contract award is for the delivery of Benlysta 200 mg/mL autoinjectors to the Defense Logistics Agency (DLA), a defense agency. The $2,556.44 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 1, 2022, with a completion date of December 22, 2022. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the medical product BENLYSTA 200 MG/ML AUTOINJECTML. The contract has a ceiling value of $24,661.36 and runs through February 14, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjectors. The contract has a ceiling value of $5,586.06 and an ultimate completion date of July 5, 2024. Amerisourcebergen, through its Corporate Office Division, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,586.06 firm fixed-price delivery order is for the supply of Benlysta 200 mg/mL autoinjectors, a specialty medication used to treat certain medical conditions. The contract has an ultimate completion date of June 21, 2024 and does not have a set-aside designation, indicating open competition. AmerisourceBergen...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB25F1253
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Benlysta 200 mg/mL autoinjector. The firm-fixed-price contract has a ceiling value of $5,586.06 and a completion date of November 25, 2024. The award is not designated as a set-aside.

AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs.

Generated 2/27/25, 1:28 PM